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ABSTRACT 
 
A total of 80 cases of acute exacerbation of chronic obstructive pulmonary disease admitted in pulmonary medicine 
ward in Siddhartha medical college, Vijayawada during the period of 18 months one & half year Jan 2008 to June 
2009 of 55 years to 75 years of both males 81% to 19% were females. 
The three commonest organisms isolated were: 1. Pseudomonas aeruginosa in 23 cases, 2. Klebsiella pneumonia in 
18 cases, and 3. Staphylococcus aureus in 14 cases. 
Antibiotics therapy either with levofloxacin or intravenous cefotaxime can be given if the exacerbation is not severe 
in case of gram negative infection. When the infection is severe, combination antibiotic therapy with cefotaxime and 
gentamicin or ciprofloxacin & gentamicin should be started. In cases where the infection is very severe or when the 
isolates are resistant to quinolones or aminoglycosides then newer antibiotics like pipericillin + Tazobactam and 
cefoperazone + sulbactam can be started 
 
Keywords: chronic obstructive pulmonary disease, Gold lines, Exacerbation, Chronic bronchitis, Biological 
research, Lung biology.  
Introduction 
 
 
 
Chronic obstructive pulmonary disease (COPD)([1]is 
defined as a common preventable & treatable disease 
which is characterized by persistent air flow limitation 
that is usually progressive & the lung to noxious 
particles or gases. Exacerbation & co-morbidities 
contribute to the overall severity in the individual 
patient. An exacerbation of COPD is defined as an  
acute event characterized by a worsening of the 
patient’s respiratory symptoms that is beyond normal 
day-to-day variations & lets to a change in 
medications[2] (GOLD guidelines2015).The 
exacerbations of infective & non-infective[3] aetiology 
have considerable impact on the health care system at 
both primary & tertiary care levels as they are a major 
reason for anti-biotic use and admissions. They let to 
indirect costs due to the days lost from work. COPD  
______________________________ 
*Correspondence  
D. Sudeena
 
Associate professor Medical College Guntur, India. 
E Mail: drsudeenaravi@gmail.com 
 
 
 
[1] affects 1-25% of patients admitted in the hospitals 
and 30% of patients seen in chest clinics. The various 
factors contributing to it or cigarette smoking, genetic 
factors and environmental risk factors like air 
pollution, occupational exposures including coal 
mining, gold mining and cotton textile dust. Although 
passive smoke exposure has been associated with 
reductions in pulmonary function, the importance of 
this risk factor in the development of the severe 
pulmonary function reductions in COPD remains 
uncertain. Of note, several genes related to the 
proteinase –antiproteinase hypothesis have been 
implicated as genetic determinants for both COPD and 
asthma, including ADAM33 and macrophage elastase. 
The role of bacterial infection in COPD exacerbations 
& use of sputum cultures to reach an etiological 
diagnosis to guide the management of the case, are 
subjects of current debate. Bacteriological studies, 
pathological investigations & clinical trials all support 
the role of bacteria and antibiotic therapy in AECOPD 
[3]. Some investigators believe that bacteria or not 
important for patients with exacerbations. But patients 
with two of the three cardinal symptoms of 
exacerbation i.e- cough with green colored sputum, 
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dyspnoea & fever should receive antibiotic therapy. 
Review of literature brings to light the data which 
shows that the bacteriological studies. The present 
studies taken upto know about the bacterial pathogens 
causing AECOPD. The fact that compelled us to take 
up this study is the empirical use of antimicrobials, rise 
in bacterial resistance, the need to assess the benefit of 
the practice, and more fundamentally the importance of 
bacterial infection in COPD, and its role in stimulating 
bronchial inflammation, which is the hallmark of this 
condition. Etiological profile, drug sensitivity pattern, 
acute factors contributing to exacerbation, duration of 
hospitalization & any complications & the impact of 
administering drugs specific for these pathogens on the 
incidence and prognosis of AECOPD is also to be 
noted. 
 
Aims & objectives 
 
 To identify the bacterial pathogens in sputum 
culture of patients admitted with AECOPD. 
 To determine the sensitivity pattern of these 
bacteria to antibiotics 
 To determine the etiological profile, drug 
sensitivity pattern, duration of hospitalization & 
any complications that occur. 
Source of data: This is hospital based prospective 
observational study comprising of 80 patients 
diagnosed with AECOPD [3] from Govt. General 
Hospital, Siddhartha Medical College, Vijayawada. 
Period of study: Over a period of 18 months (One & 
half year) (Jan 2008 to June 2009) 
Types of study: Hospital based prospective 
observational Study. 
Sample size: 80 cases of AECOPD admitted in the 
Dept. Of pulmonary Medicine at Siddhartha Medical 
College Hospital, Vijayawada. 
Sample collection: After clinical examination, routine 
CBP, blood sugar, urine examination, X-ray chest PA 
view, oxygen saturation by pulse oximetry, were done 
in all the patients. Their early morning sputum was 
collected in a sterile transparent container after rinsing 
the mouth with antiseptic solution & nebulising with 
bronchodilator. Samples were labeled and numbered 
after their receipt in the laboratory and processed by 
conventional methods. The sputum sample was 
examined for physical appearance, gram stain, AFB 
smear, pyogenic culture and drug sensitivity for 
bacteria. The duration of hospital stay & any 
complications arising were also noted.  
Processing of the samples: The sputum samples was 
collected in a sterile container & transported to the lab 
in the Microbiology Department at Siddhartha Medical 
College. Direct microscopic assessment of the slides 
were done after Gram’s staining on the day  1.on the 
next day, colony morphology,  confirmation of Gram’s 
staining, biochemical reactions are carried out on blood 
agar, Nutrients agar &Mac Conkey’s agar,. Culture & 
sensitivity is found out by growing the organisms in the 
specific petri-dishes with the antibiotics discs & noting 
the areas of inhibition.  
Method of data analysis: The data was entered into 
the Microsoft Office Excel 2010 and analysis was done 
using statistical package for social sciences (SPSS) 
version 17. Chi-square test & calculation of P value 
were done wherever necessary. Please value <0.05 is 
taken as statistically significant.  
Statistical analysis: Out of 129 cases, a total of eighty 
(80) patients were found to be have bacteria on culture 
& sensitivity which were clinically diagnosed as cases 
of acute exacerbation [2]of chronic obstructive  
pulmonary disease. Bacterial infections of AECOPD 
were analyzed. The individual bacterial isolates and 
their culture & patterns to various antibiotics were also 
recorded. 
Age distribution: The age group of the patient in the 
study, ranged from 45 to 85 years Out of 80 patients, 
the most common age group was 55 to 65 years 
(61.25%) 
 
Table 1: Age distribution 
 
AGE MALE FEMALE Total 
45-54 11 5 16 
55-64 45 4 49 
65-74 7 3 10 
75-85 2 3 5 
Total 65 15 80 
Chi-square value =11.66       degree of freedom =3  p<0.01 
Males were more compared to females in all groups, which is statistically significant 
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Fig 1: pie-diagram showing age distribution among males & females 
 
 
 
 
Fig 2:Bar diagram showing age distribution 
 
Gender distribution among AECOPD cases: Out of eighty (80) patients clinically diagnosed as acute 
exacerbation of COPD, 65(81%) were males and 15(19%) were females.  
                           
 
Fig 3:Pie-diagram showing gender distribution 
Males were more in number 65 (81%) compared to females 15 subjects (19%). 
Symptomatology:History of chronic cough with expectoration. Dyspnoea was the common clinical manifestation in 
all the patients. Majority of the patients had mucopurulent sputum.  
 
Table 3: Symptomatology 
 
Symptom Number Percentage 
Cough with expectation 80 100% 
Purulence 71 88.75% 
Dyspnoea 80 100% 
Fever 22 27.50% 
16.92% 
69.23% 
10.77% 
3.08% 
Males 
45-54 yrs
55-64 yrs
65-74 yrs
75-78 yrs
33.33% 26.67% 
20% 
20% 
Females 
45-54 yrs
55-64 yrs
65-74 yrs
75-85 yrs
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Fig 4: Individuals showing Emphysema 
 
Table 4:Variety diagram showing bacteriological profile 
 
S.NO Organisms found Number Percentage(%) 
1 E.coli 4 5 
2 Klebsiella 18 22.6 
3 Pseudomonas aeruginosa 23 28.75 
4 Acinetobacter 7 8.75 
5 Moraxella 2 2.5 
6 Strep.pyogenes 5 6.25 
7 Strep.pneumoniae 3 3.75 
8 Strep.aureus 14 17.5 
9 Strepto + Acineto 1 1.25 
     10 Klebsiella + E coli 1 1.25 
     11 Klebsiella + Pseudomonas 1 1.25 
12 E coli + Pseudomonas 1 1.25 
BACTERIOLOGICAL PROFILE:Out of eighty (80) pathogenic bacteria isolated. Seventy six (76) i. e 95% had 
single microbial infections and four (4) i..e 5% had ploy-microbial infections[7]. 
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Fig 5 :Pie-diagram showing Gram staining profile 
On gram staining there were 22 organisms (27.5%) that were gram positive and 54 organisms  (67.5%) that were 
gram negative,4(5%) that were mixed infections[4]. 
 
Fig  6: Bar diagram showing gram-positive organisms 
Total number of gram positive cultures were 22(27.5%). 
The commonest organism yielded in culture was Staph. Aureus 14(17.5%). 
The next commonest organism yielded in culture was Strep. Pyogenes 5(6.25%) 
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Fig 7: Bar-diagram showing gram negative organisms 
Total number of gram negative cultures were 54. 
The commonest organism yielded in culture was Pseudomonas 23 i.e 28.75% 
The next commonest organism yielded in culture was of Klebsiella pneumonia 18 i.e 22.5% 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 8: Bar-diagram showing mixed-organism infection 
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Fig  9: Bar-diagram depicting the various organisms isolated-Bacterial isolates. 
Commonest organisms isolated were 
Pseudomonas-23 
Klebsiella pneumonia-18, 
Streptococcus pneumonia-3, 
Streptococcus pyogenes-5, 
Acinetobaccter-7, 
Staphylococcus aureus-14, 
Moraxella-2, 
E.coli 
 
 
 
 
 
 
 
 
 
 
Fig 10: Bar diagram showing the duration of hospital stay 
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Table 5: Antibiotic sensitivity pattern of klebsiella 
 
Antibiotics Sensitivity (%) Resistant(%) Total 
Cefotaxime 10(56%) 8(44%) 18 
Ceftriaxone 9(50%) 9(50%) 18 
Ceftazidime 4(44%) 5(55%) 9 
Cefepime 6(86%) 1(14%) 7 
Levofloxacin 10(91%) 1(9%) 11 
Ciprofloxacin 9(50%) 9(50%) 18 
Amoxyclav 4(33%) 8(67%) 12 
Pipzo 8(80%) 2(20%) 10 
Cefsulbac 6(86%) 1(14%)               7 
Gentamicin 12(92%) 1(8%)               13 
Amikacin 9(90%) 1(10%)              10 
Azithromycin 0(0) 1(100%)                1 
Penicillin 0(0) 5(100%)                5 
Erythromycin 0(0) 4(100%)  4 
Amoxycillin 0(0) 7(100%) 
 
7 
 
 
Table  6: Antibiotic sensitivity pattern of pseudomonas 
 
Antibiotics Sensitivity  Resistant  Total 
Cefotaxime 11(58%) 8(42%) 19 
Ceftriaxone 10(55%) 8(44%) 18 
Ceftazidime 7(70%) 3(30%) 10 
Cefepime 6(86%) 1(14%) 7 
Levofloxacin 21(92%) 2(8%) 23 
Ciprofloxacin 20(85%) 3(15%) 23 
Amoxyclav 4(23%) 14(77%) 18 
Pipzo 19(91%) 2(9%) 21 
Cefsulbac 2(100%) 0(0%)                2 
Gentamicin 20(89%) 2(11%)               22 
Amikacin 0(0%) 4(100%)                4 
Penicillin 0(0) 11(100%)               11 
Erythromycin 0(0) 10(100%)               10 
Amoxycillin 
 
0(0) 
 
       13(100%) 
 
13 
 
 
Table 7: Antibiotic sensitivity pattern of staphylococcus aureus 
Antibiotics Sensitivity  Resistant  Total 
Cefotaxime 14(56%) 0 14 
Ceftriaxone 14(50%) 0 14 
Ceftazidime 3(44%) 0 3 
Cefepime 3(86%) 0 3 
Ciprofloxacin 3(50%) 0 3 
Amoxyclav 5(33%) 1(6%) 6 
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Pipzo 1(80%) 0 1 
Gentamicin 1(92%) 0 1 
Azithromycin 4(100%) 0 4 
Penicillin 2(50%) 2(50%) 4 
Erythromycin 2(67%) 1(33%) 3 
Amoxycillin 2(50%) 
 
2(50%) 
 
4 
 
 
 Discussion 
 
COPD is a leading cause of morbidity and mortality. 
An exacerbation of COPD (AECOPD) is an acute 
event characterized by a worsening of the patients 
respitory symptoms that is beyond normal day-to-day 
variations &leads to a change in medications[3] 
(GOLD guidelines 2015).Exacerbations of 
COPD[6]are important events in the course of the 
disease because they: 
 Negatively affect a patient’s quality of life 
 Have effects on lung functions that take several 
weeks to recover 
 Accelerate the rate of decline of the lung 
functions 
 Are associated with significant mortality 
especially in the hospitalized patients 
 Have high socio-economic costs. 
                   In-hospital mortality of a patients admitted 
for a hypercapnic exacerbation with acidosis id 
approximately 10%.Mortality reaches 40% at 1year 
after discharge in those needing mechanical support. 
All-cause mortality 3 years after hospitalization is as 
high as 49%. Prevention, early detection & prompt 
treatment of exacerbations are vital to reduce the 
burden of COPD Exacerbations are precipitated by 
several factors, the most common being respitory tract 
infections. Infections play a major role in the etiology 
of acute exacerbations (Ball 1995). 
Three classes of pathogens have been implicated as 
causing acute exacerbation of COPD by infecting the 
lower respiratory tract. 
1) Respiratory viruses - <10% 
2) Atypical bacteria – 30% 
3) Aerobic Gram positive and gram negative 
bacteria – 50% 
In our study, 
 40% of patients were in the age group of 55-65 
years, followed by 65-75 years 
 65(81%) were males and 15(19%) were females. 
Most of the males were in the age group of 55 to 
65 years. 
 Males were more compared to females in all 
groups. This is statistically significant. 
 Among the males, 62(95%) were smokers and 
3(5%) were non-smokers. Most of the females 
were Beedi-rollers by profession 9(60%)[6]. 
 Chronic cough with expectoration & dyspnoea 
were the presenting symptoms in all the patients. 
 Characteristics of the patients in the present 
study: 
            No of subjects                     80 
            Males & females                65(81%) 15(19%) 
            Age                                     55-65(40%)  
            Smoking: 
            Smokers                                               62(95%) 
            Nonsmokers                                         3(5%) 
            Number of exacerbation last year        2.3(0-6) 
Bacteriological profile: 
In our study out of eighty (80) pathogenic bacteria 
isolated. Seventy six  (76) i.e 95% had single microbial 
infections and four (4) i.e 5% had polymicrobial 
infections. On gram staining there were 23 organisms 
(28.75%) that were gram positive and 57 organisms 
(71.25%) that were gram negative 
Gram negative organisms were isolated in 57 patients. 
 The commonest organisms yielded in culture was 
Pseudomonas 23 i.e 28.75%. 
The three commonest organisms isolated in our study 
were: 
1) Pseudomonas aeruginosa    in 23 cases 
2) Kiebsiella pneumonia            in 18 cases, and 
3) Staphylococcus aureus         in 14 cases 
The various organisms isolated were is as follows: 
Pseudomonas -23, Klebsiella pneumonia -18, 
Streptococcus pneumonia -3, Streptococcus pyogenes -
5, Acinetobacter -7, Stsphylococcus aureus -14, 
Moraxella -2, E.coll -4The most predominant 
organisms causing  (7)AECOPD were gram negative 
pseudomonas, there were no isolated of H.influenza. 
Pseudomonas aeruginosa was isolated in 23(28.75%), 
Klebsiella pneumonia in 18(22.5%). This is similarity 
with most of the studies that shows a predominance of 
gram negative organisms. 
In our study we found that: 
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 Aminopenicillins with beta-lactamase inhibitor 
were not effective against both Klebsiella and 
Pseudomonas. 
 Klebsiella was sensitive to a combination of 
levofloxacin and gentamicin, sensitivity being 
92%. 
 Ciprofloxacin and gentamicin, sensitivity being 
85% or 
 Pseudomonas aeruginosa was sensitive to a 
combination of ciprofloxacin and  
 Gentamicin sensitivity being 87% or a 
combination of levofloxacin and gentamicin with 
sensitivity of 91%. 
The potential indications for hospital admission in 
AECOPD patients are: 
 Marked increase in intensity of symptoms , such 
as sudden development of resting dyspnoea. 
 Severe underlying COPD[8]. 
 Onset of new physical signs like cyanosis, 
peripheral edema. 
 Failure of an exacerbation to respond to initial 
medical management. 
 Presence of serious co-morbidities. 
 Frequent exacerbations. 
 Older age 
 In the current study, the average hospital stay was 
about a week. Further extensive study in a larger 
population for an extended period is required to 
confirm & correlate these finding to apply them in the 
day to day practice. 
 
Conclusion 
 
The commonest organisms causing acute exacerbation 
of COPD [9] in our study were gram negative 
organisms. Most common gram negative organisms 
isolated were pseudomonas aeruginosa followed by 
Klebsiella pneumonia. They were sensitive to 
levofloxacin, cephalosporins and gentamicin. So initial 
empirical anti biotic therapy can be started with a 
combination of levofloxacin with gentamicin. 
Cephalosporins with or without beta-lactamase 
inhibitors like clavulanic acid, surfactants or 
Tazobactam are to be given in patients with severe 
infections or complications.  Most commonly isolated 
gram positive organism was staphylococcus aureus. 
Which was sensitive to both levofloxacin and 
cefotaxime. In our study, most of the organisms were 
resistant to Amoxicillin, Amoxicillin, & co-theraphy. 
Single antibiotic therapy either with levofloxacin or 
intravenous cefotaxime can be given if the 
exacerbation is not severe In conclusion, atypical 
pathogens[10] as well as typical bacteria may have a 
role in acute exacerbations of COPD. High resistance 
to commonly used antibiotics for typical agents and 
mixed infections in these severe functionally impaired 
cases of COPD were remarkable.  
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